Isbn: 9789401072892 - current directions in radiopharmaceutical research and development: 30 (8 risultati)

Perfeziona la tua ricerca

  • Libri (8)

  • Nuovo (8)

a

Fascia di prezzo personalizzata (EUR)

a

  • Lingua: Inglese

    Editore: Springer, 2011

    9401072892 / 9789401072892

    Serie: Libro 17 di 33 - Developments in Nuclear Medicine

    • Brossura

    Da: Ria Christie Collections, Uxbridge, Regno UnitoRia Christie Collections

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 183,07

    EUR 10,97 spedizione 
    Spedito da Regno Unito a U.S.A.

    Quantità: Più di 20 disponibili

    Condizione: New. In English.

  • Lingua: Inglese

    Editore: Springer, 2011

    9401072892 / 9789401072892

    Serie: Libro 17 di 33 - Developments in Nuclear Medicine

    • Brossura

    Da: California Books, Miami, FL, U.S.A.California Books

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 195,50

     Spedizione gratuita 
    Spedito in U.S.A.

    Quantità: Più di 20 disponibili

    Condizione: New.

  • Lingua: Inglese

    Editore: Springer, 2011

    9401072892 / 9789401072892

    Serie: Libro 17 di 33 - Developments in Nuclear Medicine

    • Brossura

    Da: AHA-BUCH GmbH, Einbeck, GermaniaAHA-BUCH GmbH

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 173,47

    EUR 35,00 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: 1 disponibile

    Taschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Radiophannaceutical research has recently undergone a major change in direction. In past years it has been concerned mainly with the development of perfusion tracers, the biodistribution of which reflect the regional blood flow to areas of major organs such as the heart and brain. However, a major new direction of interest now lies in the development of receptor-binding radio-tracers which can be used to perform in-vivo characterisation of diseased tissues and it is likely that much of the future research in this field will follow this direction. The difficulties in developing such tracers are considerable. The researcher must first identify a promising target for radiopharmaceutical development. High specific activity radioactive molecules must be designed and synthesised which will both bind to the target receptor with high affinity, and also have the physicochemical characteristics which will allow them to reach the target site in sufficient quantity while at the same time showing minimal uptake in non-target tissues. Thus the knowledge base required for radiophannaceutical development has now expanded beyond the limits of radiopharmaceutical chemistry to include aspects of biochemistry, molecular biology and conventional drug design. The portfolio of basic knowledge required to support current radiopharmaceutical development is changing and scientists working in this arena need to be trained in this regard. At the same time, the very latest developments in the field need to be communicated to the scientific community in order to stimulate the advancement of this exciting new direction of research.…

  • Lingua: Inglese

    Editore: Springer, 2012

    9401072892 / 9789401072892

    Serie: Libro 17 di 33 - Developments in Nuclear Medicine

    • Brossura

    Da: Revaluation Books, Exeter, Regno UnitoRevaluation Books

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 237,78

    EUR 11,71 spedizione 
    Spedito da Regno Unito a U.S.A.

    Quantità: 2 disponibili

    Paperback. Condizione: Brand New. reprint edition. 260 pages. 9.44x6.31x0.59 inches. In Stock.

  • Lingua: Inglese

    Editore: Springer, 2011

    9401072892 / 9789401072892

    Serie: Libro 17 di 33 - Developments in Nuclear Medicine

    • Brossura
    • Print on Demand

    Da: Brook Bookstore On Demand, Napoli, NA, ItaliaBrook Bookstore On Demand

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 126,26

    EUR 5,50 spedizione 
    Spedito da Italia a U.S.A.

    Quantità: Più di 20 disponibili

    Condizione: new. Questo è un articolo print on demand.

  • Lingua: Inglese

    Editore: Springer Netherlands, Springer Netherlands Sep 2011, 2011

    9401072892 / 9789401072892

    Serie: Libro 17 di 33 - Developments in Nuclear Medicine

    • Brossura
    • Print on Demand

    Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, GermaniaBuchWeltWeit Ludwig Meier e.K.

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 160,49

    EUR 23,00 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: 2 disponibili

    Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Radiophannaceutical research has recently undergone a major change in direction. In past years it has been concerned mainly with the development of perfusion tracers, the biodistribution of which reflect the regional blood flow to areas of major organs such as the heart and brain. However, a major new direction of interest now lies in the development of receptor-binding radio-tracers which can be used to perform in-vivo characterisation of diseased tissues and it is likely that much of the future research in this field will follow this direction. The difficulties in developing such tracers are considerable. The researcher must first identify a promising target for radiopharmaceutical development. High specific activity radioactive molecules must be designed and synthesised which will both bind to the target receptor with high affinity, and also have the physicochemical characteristics which will allow them to reach the target site in sufficient quantity while at the same time showing minimal uptake in non-target tissues. Thus the knowledge base required for radiophannaceutical development has now expanded beyond the limits of radiopharmaceutical chemistry to include aspects of biochemistry, molecular biology and conventional drug design. The portfolio of basic knowledge required to support current radiopharmaceutical development is changing and scientists working in this arena need to be trained in this regard. At the same time, the very latest developments in the field need to be communicated to the scientific community in order to stimulate the advancement of this exciting new direction of research. 260 pp. Englisch.…

  • Lingua: Inglese

    Editore: Springer Netherlands, 2011

    9401072892 / 9789401072892

    Serie: Libro 17 di 33 - Developments in Nuclear Medicine

    • Brossura
    • Print on Demand

    Da: moluna, Greven, Germaniamoluna

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 136,16

    EUR 48,99 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: Più di 20 disponibili

    Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Radiophannaceutical research has recently undergone a major change in direction. In past years it has been concerned mainly with the development of perfusion tracers, the biodistribution of which reflect the regional blood flow to areas of major organs such.…

  • Lingua: Inglese

    Editore: Springer Netherlands, Springer Netherlands Sep 2011, 2011

    9401072892 / 9789401072892

    Serie: Libro 17 di 33 - Developments in Nuclear Medicine

    • Brossura
    • Print on Demand

    Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germaniabuchversandmimpf2000

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 160,49

    EUR 60,00 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: 1 disponibile

    Taschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Radiophannaceutical research has recently undergone a major change in direction. In past years it has been concerned mainly with the development of perfusion tracers, the biodistribution of which reflect the regional blood flow to areas of major organs such as the heart and brain. However, a major new direction of interest now lies in the development of receptor-binding radio-tracers which can be used to perform in-vivo characterisation of diseased tissues and it is likely that much of the future research in this field will follow this direction. The difficulties in developing such tracers are considerable. The researcher must first identify a promising target for radiopharmaceutical development. High specific activity radioactive molecules must be designed and synthesised which will both bind to the target receptor with high affinity, and also have the physicochemical characteristics which will allow them to reach the target site in sufficient quantity while at the same time showing minimal uptake in non-target tissues. Thus the knowledge base required for radiophannaceutical development has now expanded beyond the limits of radiopharmaceutical chemistry to include aspects of biochemistry, molecular biology and conventional drug design. The portfolio of basic knowledge required to support current radiopharmaceutical development is changing and scientists working in this arena need to be trained in this regard. At the same time, the very latest developments in the field need to be communicated to the scientific community in order to stimulate the advancement of this exciting new direction of research.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 260 pp. Englisch.…